Cerebral blood flow and metabolic abnormalities in Alzheimer's disease

被引:179
|
作者
Matsuda, H [1 ]
机构
[1] Natl Ctr Hosp Mental Nervous & Muscular Disorders, Natl Ctr Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 1878551, Japan
关键词
Alzheimer's disease; SPECT; PET; regional cerebral blood flow; regional cerebral metabolic rate for glucose;
D O I
10.1007/BF02988596
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In this review I summarize observations of PET and SPECT studies about cerebral blood Row and metabolic abnormalities in Alzheimers disease. In very early AD flow or metabolism reduces first in the posterior cingulate gyrus and precuneus. This reduction may arise from functional deafferentation caused by primary neural degeneration in the remote area of the entorhinal cortex that is the first to be pathologically affected in AD. Then medial temporal structures and parietotemporal association cortex show Row or metabolic reduction as disease processes. The reason why Row or metabolism in medial temporal structures shows delay in starting to reduce in spite of the earliest pathological affection remains to be elucidated. It is likely that anterior cinpulate gyrus is functionally involved, since attention is the first non-memory domain to be affected, before deficits in language and visuospatial functions. However few reports have described involvement in the anterior cingulate: gyrus. Relationship between cerebral blood Row or metabolism and apolipoprotein E genotype has been investigated. Especially, the APOE epsilon4 allele: has been reported to increase risk and to lower onset age as a function of the inherited dose of the epsilon3 allele. Reduction of flow or metabolism in the posterior cingulate gyrus and precuneus has been reported even in presymptomatic nondemented subjects who were cognitively normal and had at least a single epsilon3 allele. On the contrary the relation of epsilon4 allele to the progression rate of AD has been controversial From neuroimaging approaches. PET and SPECT imaging has become to be quite useful fur assessing therapeutical effects of newly introduced treatment For AD. Recent investigations observed significant regional flow increase after donepezil hydrochloride treatment. Most of these observations have been made by applying computer assisted analysis of three-dimensional stereotactic surface projection or statistical parametric mapping instead of a conventional regions of interest technique.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 50 条
  • [1] Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease
    Hiroshi Matsuda
    Annals of Nuclear Medicine, 2001, 15 : 85 - 92
  • [2] Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease
    Lacalle-Aurioles, Maria
    Mateos-Perez, Jose M.
    Guzman-De-Villoria, Juan A.
    Olazaran, Javier
    Cruz-Orduna, Isabel
    Aleman-Gomez, Yasser
    Martino, Maria-Elena
    Desco, Manuel
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (04): : 654 - 659
  • [3] Cerebral blood flow in Alzheimer's disease
    Roher, Alex E.
    Debbins, Josef P.
    Malek-Ahmadi, Michael
    Chen, Kewei
    Pipe, James G.
    Maze, Sharmeen
    Belden, Christine
    Maarouf, Chera L.
    Thiyyagura, Pradeep
    Mo, Hua
    Hunter, Jesse M.
    Kokjohn, Tyler A.
    Walker, Douglas G.
    Kruchowsky, Jane C.
    Belohlavek, Marek
    Sabbagh, Marwan N.
    Beach, Thomas G.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 599 - 611
  • [4] Eye-head coordination abnormalities and regional cerebral blood flow in Alzheimer's disease
    Nakano, N
    Hatakeyama, Y
    Fukatsu, R
    Hayashi, S
    Fujii, M
    Fujimori, K
    Takahata, N
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1999, 23 (06): : 1053 - 1062
  • [5] Regional Cerebral Blood Flow Abnormalities Associated With Apathy and Depression in Alzheimer Disease
    Kang, Ji Yeon
    Lee, Jae Sung
    Kang, Hyejin
    Lee, Hae-Woo
    Kim, Yu Kyeong
    Jeon, Hong Jin
    Chung, June-Key
    Lee, Myung Chul
    Cho, Maeng Je
    Lee, Dong Soo
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2012, 26 (03): : 217 - 224
  • [6] Hypertension and cerebral blood flow in the development of Alzheimer's disease
    Bachmann, Dario
    Saake, Antje
    Studer, Sandro
    Buchmann, Andreas
    Rauen, Katrin
    Gruber, Esmeralda
    Michels, Lars
    Nitsch, Roger M.
    Hock, Christoph
    Gietl, Anton
    Treyer, Valerie
    ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 7729 - 7744
  • [7] Clinical studies of cerebral blood flow in Alzheimer's disease
    Jagust, WJ
    Eberling, JL
    Reed, BR
    Mathis, CA
    Budinger, TF
    CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 : 254 - 262
  • [8] Altered Cerebral Blood Flow in Alzheimer's Disease With Depression
    Li, Runzhi
    Zhang, Yanling
    Zhuo, Zhizheng
    Wang, Yanli
    Jia, Ziyan
    Sun, Mengfan
    Zhang, Yuan
    Li, Wenyi
    Duan, Yunyun
    Yao, Zeshan
    Weng, Haoyi
    Wei, Juan
    Liu, Yaou
    Xu, Jun
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [9] Systemic metabolic abnormalities in Alzheimer's disease
    Swerdlow, R. H.
    Onyango, I.
    Anderson, H. S.
    Brooks, W. M.
    Burns, J. M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 272 - 272
  • [10] Blood Pressure and Cerebral Blood Flow in Alzheimer Disease
    Nation, Daniel A.
    HYPERTENSION, 2018, 72 (01) : 68 - 69